Skip to main content
Caplight Logo









Neuron Guard

Neuron Guard

Private
ModenaHealthcare & Life Scienceshttps://neuronguard.com/

Last Round

Convertible Debt

Nov 4, 2021

Total Funding Raised

$2.16M

Company Overview

Neuron Guard is a medtech company that develops and manufactures a portable system for targeted temperature management to treat patients with acute brain injuries.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

therapeutic hypothermiacerebral coolingacute brain injurymedical deviceemergency medical servicesEMStemperature managementstroke treatmenttraumatic brain injuryTBIpoint of carePOCneuroprotectionportable coolingmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Neuron Guard Comparables

Compare Neuron Guard with similar companies based on industry and business-model similarity.

Neuron Guard comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Global Healthcare SG Pte. Ltd.
78%
BrainCool AB
77%
Neomend
71%

Neuron Guard Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Convertible DebtNov 4, 2021
GrantSep 3, 2018
SeedDec 23, 2015
GrantNov 28, 2013

Key People

Founding team and executive leadership

Mary Franzese

Cofounder And CMO, Chief Marketing Officer

Founding Team

Enrico Giuliani

CEO

Executive Team

Neuron Guard Investors

Notable investors and investment history

Neuron Guard investors
InvestorRounds
2031Grant
CDP Venture Capital SGRConvertible Debt
Türk Telekom VenturesGrant
A11 VentureConvertible Debt, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 4, 2021

    $1.37M raised with CDP Venture Capital and fondo-rilancio-startup leading.

Neuron Guard Filings

Explore SEC and related filing metadata, where available.

Neuron Guard filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Neuron Guard's valuation, stock price, and market status.

Is Neuron Guard a public or private company?

Neuron Guard is a private company.

What is the current stock price of Neuron Guard?

Neuron Guard is a private company with no public stock price. No recent secondary market data is available.

How much is Neuron Guard worth (valuation)?

Valuation information for Neuron Guard is not publicly available.

Can I buy Neuron Guard stock?

Neuron Guard shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Neuron Guard's last funding round?

Neuron Guard's most recent funding round was VC Round on November 4, 2021.

Who are the main investors in Neuron Guard?

Key investors in Neuron Guard include CDP Venture Capital SGR, A11 Venture.

Will Neuron Guard IPO soon?

No public IPO plans have been announced for Neuron Guard.

How can I track Neuron Guard secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Neuron Guard's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersModena
Employee Range3
Year Founded2013
Last FundingNov 4, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?